UNITY Biotechnology (@unitybiotech) 's Twitter Profile
UNITY Biotechnology

@unitybiotech

UNITY is harnessing pathways of aging biology to develop new senolytic medicines, with a focus on retinal diseases | $UBX

ID: 713476080510763009

linkhttp://unitybiotechnology.com/ calendar_today25-03-2016 21:22:08

420 Tweet

5,5K Takipçi

97 Takip Edilen

UNITY Biotechnology (@unitybiotech) 's Twitter Profile Photo

We're extending our Phase 2b ASPIRE Clinical Study evaluating #UBX1325 in DME from 24 weeks to 36 weeks, allowing us to assess potentially greater durability compared to standard of care. Learn more about our next steps: bit.ly/3xP09jw $UBX